Showing results (311-320 of 429) with videos related to
Sort By:
Pageof 43
Nature Cell Biology|April 3, 2001
Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaBR Ravi, G C Bedi, L W Engstrom, et al.Clinical Transplants|January 1, 1994
Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North AmericaP A Rowlings, J R Passweg, J O Armitage, et al.Annals of Internal Medicine|March 1, 1985
Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapyR E Champlin, W G Ho, R P Gale, et al.Bone Marrow Transplantation|January 1, 1992
Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late EffectsH J Kolb, W Guenther, T Duell, et al.Antimicrobial Agents and Chemotherapy|May 19, 2000
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteersC W Hendrix, C Flexner, R T MacFarland, et al.Annals of Internal Medicine|July 1, 1986
Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trialR T Mitsuyasu, R E Champlin, R P Gale, et al.Cancer Research|October 27, 1998
p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300R Ravi, B Mookerjee, Y van Hensbergen, et al.Blood|February 15, 1993
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?O Ringdén, M M Horowitz, P Sondel, et al.Bone Marrow Transplantation|August 1, 1995
Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remissionR P Gale, M M Horowitz, R S Weiner, et al.Blood|October 1, 1993
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phaseJ M Goldman, R Szydlo, M M Horowitz, et al.Pageof 43